Form 4: Aura Biosciences Director Johnson Increases Stake in Company

Director David Michael Johnson reports purchasing 20,000 shares of Aura Biosciences and warrants for 5,000 shares in a recent transaction.

Summary

• On May 16, 2025, David Michael Johnson, a director of Aura Biosciences, Inc., purchased 20,000 shares of common stock at $4.90 per share.
• Johnson also acquired warrants to purchase an additional 5,000 shares at the same price.
• Following the transaction, Johnson directly owns 166,167 shares.
• Johnson also has indirect ownership through several irrevocable trusts and Velocity Capital Management.
• The filing also includes a Power of Attorney, granting Conor Kilroy and Amy Elazzouzi the authority to act on Johnson's behalf for SEC filings related to Aura Biosciences securities.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the director's purchase of shares and warrants, indicating confidence in the company. However, it's a single transaction and needs to be considered in the context of overall market conditions and company performance.

Positives

• The director's purchase of shares and warrants signals confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. However, it's important to consider the size of the purchase relative to the director's existing holdings and the overall market capitalization of the company.

Comparison to Industry Standards

• Comparing Johnson's transactions to other insider activity in the biotechnology sector could provide context.
• For example, if other directors in comparable companies like Iovance Biotherapeutics or Adaptimmune Therapeutics are also increasing their holdings, it could signal a broader positive sentiment towards the industry.
• Conversely, if insider selling is more prevalent, it could raise concerns.

Stakeholder Impact

• The director's increased investment could positively influence shareholder confidence.
• Employees may view this as a positive sign of leadership's belief in the company's success.

Key Dates

Keywords

Aura Biosciences, Director, Johnson, Stock Purchase, Warrants, Beneficial Ownership, SEC Form 4, Insider Trading